Streetbeat News

Earnings

FRPT

Freshpet Inc (NASDAQ:FRPT) reported Q3 FY23 sales growth of 32.6% YoY to $200.60 million, beating the analyst consensus estimate. Gross profit increased 48.9% YoY to $66.3 million, with the margin expanding from 29.4% to 33%. The company raised its FY23 sales outlook from ~$750 million to ~$755 million and adjusted EBITDA guidance from at least $55 million to ~$62 million. FRPT shares traded higher by 11.50% premarket Monday.

Portfolio Pulse from Shivani Kumaresan

November 06, 2023 | 1:39 pm

TGLS

Tecnoglass reported its Q3 financial results and updated guidance, which led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:36 pm

AMZN

RIVN

TSLA

Rivian Automotive Inc is set to report Q3 earnings with an expected negative EPS of $1.33 and revenue of $1.31 billion. The company's R2 model, set to be revealed in 2024, is a significant focus for future revenues. However, Rivian's recent fundraising and stock dilution, along with significant cash burn, have caused investor caution. Despite a 45% drop in stock price over the past year, analysts see a potential buy opportunity, with price targets ranging from $24 to $31. Rivian's partnership with Amazon for EDV deliveries in Germany is also seen as a positive.

Portfolio Pulse from Surbhi Jain

November 06, 2023 | 1:33 pm

DHC

Definitive Healthcare has published its Q3 financial results materials, leading to a rise in its share prices.

Portfolio Pulse from Luke J Jacobi

November 06, 2023 | 1:28 pm

POST

Post Holdings has projected its Q4 2023 revenue to be $1.9 billion, which is slightly lower than the estimated $1.94 billion.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:16 pm

ES

Eversource Energy (NYSE:ES) reported Q3 FY23 revenue of $2.79 billion, missing the consensus of $3.295 billion. Adjusted EPS of $0.97 also missed the consensus of $0.98. Earnings declined across most segments, with the exception of the Electric Transmission segment. The company has adjusted its FY23 EPS outlook to $4.30-$4.43, from $4.25-$4.43. ES shares are trading higher by 2.12% at $55.43 premarket.

Portfolio Pulse from Lekha Gupta

November 06, 2023 | 1:13 pm

KROS

Keros Therapeutics reported Q3 losses of $(1.33) per share, beating the analyst consensus estimate of $(1.35) by 1.48 percent. This is a 44.57 percent increase in losses from the same period last year. The company's cash and cash equivalents of $287.9M are expected to fund its operating expenses and capital expenditure requirements into Q4 of 2025.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:10 pm

RYAAY

Ryanair reported its 1H financial results, showing a 72% increase in year over year EPS. This positive news has led to a rise in the company's share price.

Portfolio Pulse from Luke J Jacobi

November 06, 2023 | 1:09 pm

VVX

V2X has revised its FY23 adjusted EPS outlook downwards to $3.50-$3.75 from the previous $3.85-$4.30.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:09 pm

VVX

V2X reported Q3 adjusted earnings of $0.73 per share, beating the analyst consensus estimate of $0.15 by 386.67%. However, this is a 45.93% decrease from the same period last year. The company also reported quarterly sales of $1.00 billion, beating the analyst consensus estimate of $966.71 million by 3.44%, marking a 4.37% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:06 pm